Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis-Reference-Cited by-同舟云学术

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis

Published:2021-12 Issue: Volume: Page:
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Song Nazi,Xu Hongjiao,Liu Jiahua,Zhao Qian,Chen Hui,Yan Zhibin,Yang Runling,Luo Zhiteng,Liu Qi,Ouyang Jianmei,Wu Shuohan,Luo Suijia,Ye Shuyin,Lin Runfeng,Sun Xi,Xie Junqiu,Lan Tian,Wu Zhongdao,Wang Rui,Jiang Xianxing

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference50 articles.

1. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts;Weiskirchen;F1000Res,2018

2. Pathogenesis of liver fibrosis;Hernandez-Gea;Annu Rev Phytopathol,2011

3. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways;Zhang;Nat Commun,2017

4. Mechanisms of hepatic stellate cell activation;Tsuchida;Nat Rev Gastroenterol Hepatol,2017

5. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation;Mannaerts;J Hepatol,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism;Diabetes & Metabolism Journal;2024-05-31

2. Design and Synthesis of Novel Ultralong-Acting Peptides as EDP-EBP Interaction Inhibitors for Pulmonary Fibrosis Treatment;Journal of Medicinal Chemistry;2024-04-08

3. Glucagon-like peptide-1 analogs: Miracle drugs are blooming?;European Journal of Medicinal Chemistry;2024-04

4. Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature;International Journal of Molecular Sciences;2024-03-29

5. Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists;Journal of Medicinal Chemistry;2023-12-20